Navigation Links
Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
Date:10/7/2008

In a clinical study of adults, VYVANSE taken once-daily significantly improved the symptoms of ADHD within one week

PHILADELPHIA, Oct. 7 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that a study published in the September issue of the Journal of Clinical Psychiatry found once-daily VYVANSE significantly improved Attention Deficit Hyperactivity Disorder (ADHD) symptoms in adults within the first week of treatment. This study is the phase 3 pivotal trial submitted to the FDA and supported the approval in April 2008 of VYVANSE for adults with ADHD. VYVANSE was introduced in July 2007 for the treatment of ADHD in children aged 6 to 12 years and is now the fastest-growing ADHD prescription medication in the United States.

"This study adds to the growing body of research of ADHD in adults, and showed that VYVANSE provided effective symptom control for adults with this disorder," said Lenard A. Adler, M.D., lead researcher in this study and director of the Adult ADHD program at the NYU Langone Medical Center, associate professor of psychiatry, neurology and child and adolescent psychiatry at the New York University School of Medicine, as well as author of Scattered Minds: Help and Hope for Adults with ADHD (G. P. Putnam's Sons 2006). "It is important for people to realize that in adults, the core symptoms of ADHD -- inattention, hyperactivity, and impulsivity -- may present as inner restlessness, a lack of focus and organization, poor time management, or an inability to finish tasks, which can impact adults' daily lives. In this study, VYVANSE was shown, within the first week, to significantly improve ADHD symptoms of inattention, such as the ability to focus and organize, and hyperactivity and impulsivity, such as restlessness, and interrupting."

VYVANSE Significantly Improved ADHD Symptoms in Adults

In this randomized, double-blind, placebo-controlled, par
'/>"/>

SOURCE Shire Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Reportbuyer.com has added a new market research ... https://www.reportbuyer.com/product/2225723/Global-Bone-Densitometers-Market-2014-2018.html ... special type of X-ray test used to measure the ... to detect osteopenia or osteoporosis, diseases in which the ... is high. The purpose of bone densitometry is to ...
(Date:7/28/2014)... -- June 28 th , 2014 – Oncolab, the ... cancer test, is making its AACC debut (booth #4051) at ... is a serum-based in vitro immunoassay, has been run for ... in the fight against cancer recurrence. Photo - ... million cancer survivors in the US alone, the race is ...
(Date:7/28/2014)...  Surgical Theater, LLC announced today the addition ... Board. New members include Ori J. Braun ... and New Technologies for Given Imaging Ltd., and ... President and General Manager of Philips Healthcare,s Computer ... technology to brain surgery and has developed software-based ...
Breaking Medicine Technology:Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5
... FRANCISCO, Calif. , March 15 Poniard Pharmaceuticals, ... innovative oncology therapies, today announced the sale of 4,229,000 of ... Ltd. for gross proceeds of approximately $6.3 million , ... committed equity financing facility with Commerce Court.  Poniard intends to ...
... Caliper Life Sciences, Inc. (Nasdaq: CALP ), a ... life sciences research, today announces that it has entered into ... subsidiary Shimadzu Scientific Instruments, Inc., resolving a lawsuit filed by ... District of Texas that claimed that Shimadzu,s MultiNA ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces $6.3 Million Financing 2Poniard Pharmaceuticals Announces $6.3 Million Financing 3Poniard Pharmaceuticals Announces $6.3 Million Financing 4Caliper Settles Outstanding Litigation with Shimadzu 2
(Date:7/28/2014)... 28, 2014 Ticket Down is ... Champions Cup Match between Manchester City and Liverpool FC ... Bronx has hosted countless big events since it opened several ... of the original Yankee Stadium, however, it has been a ... City metro area. , The Yankees Stadium is the ...
(Date:7/28/2014)... UHY LLP, a member of the global ... International Business – Issue 29. This bi-annual publication features ... current business challenges and key issues faced by companies ... following topics:, , Key industry sectors ... the next five years? Where are growth opportunities to ...
(Date:7/28/2014)... students seem to be satisfied with the healthier school lunches ... school officials. , , New meal standards -- issued by ... the fall of 2012. At the time, there was concern ... of their food. But the new study of nearly 600 ... "The updated meals standards are resulting in healthier meals for ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Glutamine is ... and it’s considered to be conditionally essential during times ... is an advanced recovery & Immune System Support. , ... glutamine your body produces, supplementing with additional glutamine may ... waste products in the body, digestion and immune system ...
(Date:7/28/2014)... researchers report that an alternative to the traditional handshake ... experiments, the scientists found that clasping hands transferred about ... other than what is known as a fist bump. ... a cultural substitute for the firm gripping of hands. ... of the American Journal of Infection Control . ...
Breaking Medicine News(10 mins):Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 2Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 3Health News:Uhy International Business Issue 29 Now Available 2Health News:Uhy International Business Issue 29 Now Available 3Health News:Healthy School Lunches Get Thumbs Up From Students 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3
... A hospital group based in McAllen, Texas, has agreed to ... it violated the False Claims Act, the Anti-Kickback Statute and ... compensation to doctors in order to induce them to refer ... today. McAllen Hospitals L.P., d/b/a/ South Texas Health System, is ...
... , - Calls on Congress to Address Long Term ... 30 At a briefing by the Leadership Council of Aging ... Council on Aging (NCOA), applauded the House for making the CLASS ... Health Care for America Act and urged the Senate to include ...
... new drugs in pipeline , FRIDAY, Oct. 30 (HealthDay ... present a major public health problem, said scientists gathering ... Friday. , Chief among the concerns are resistant gram-negative ... and otherwise healthier people. The troubling trend is compounded ...
... more go up, study finds , FRIDAY, Oct. 30 (HealthDay ... dialysis, a U.K. study has found. , Researchers at the ... information on 69 dialysis patients who had traveled in Europe, ... Rim and South Asia. , One person died while traveling, ...
... , BIRMINGHAM, Ala., Oct. 30 WakeMed Health & ... a Letter of Understanding (LOU) under which the two ... http://www.newscom.com/cgi-bin/prnh/20080812/CLTU111LOGO ) , These opportunities may include WakeMed ... Blue Ridge Surgery Center with SCA continuing to manage ...
... new study from a researcher at Harvard University finds that ... while straight men prefer the most feminine-faced women. The ... wired for attraction to sexually dimorphic facesthose with facial features ... The research is currently published online in the journal ...
Cached Medicine News:Health News:Texas Hospital Group Pays U.S. $27.5 Million to Settle False Claims Act Allegations 2Health News:Texas Hospital Group Pays U.S. $27.5 Million to Settle False Claims Act Allegations 3Health News:National Council on Aging's Firman Lauds CLASS Act as Part of House Health Care Bill 2Health News:National Council on Aging's Firman Lauds CLASS Act as Part of House Health Care Bill 3Health News:Antibiotic Resistance Still a Major Public Health Threat 2Health News:Antibiotic Resistance Still a Major Public Health Threat 3Health News:Antibiotic Resistance Still a Major Public Health Threat 4Health News:WakeMed and Surgical Care Affiliates Enter into Venture for Ambulatory Surgery 2Health News:WakeMed and Surgical Care Affiliates Enter into Venture for Ambulatory Surgery 3Health News:For gay and straight men, facial attraction operates similarly 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: